Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration
17
Zitationen
8
Autoren
2023
Jahr
Abstract
BACKGROUND: The significance of liver metastasis (LM) in increasing the risk of death for postoperative colorectal cancer (CRC) patients necessitates innovative approaches to predict LM. AIM: Our study presents a novel and significant contribution by developing an interpretable fusion model that effectively integrates both free-text medical record data and structured laboratory data to predict LM in postoperative CRC patients. METHODS: We used a robust dataset of 1463 patients and leveraged state-of-the-art natural language processing (NLP) and machine learning techniques to construct a two-layer fusion framework that demonstrates superior predictive performance compared to single modal models. Our innovative two-tier algorithm fuses the results from different data modalities, achieving balanced prediction results on test data and significantly enhancing the predictive ability of the model. To increase interpretability, we employed Shapley additive explanations to elucidate the contributions of free-text clinical data and structured clinical data to the final model. Furthermore, we translated our findings into practical clinical applications by creating a novel NLP score-based nomogram using the top 13 valid predictors identified in our study. RESULTS: The proposed fusion models demonstrated superior predictive performance with an accuracy of 80.8%, precision of 80.3%, recall of 80.5%, and an F1 score of 80.8% in predicting LMs. CONCLUSION: This fusion model represents a notable advancement in predicting LMs for postoperative CRC patients, offering the potential to enhance patient outcomes and support clinical decision-making.
Ähnliche Arbeiten
Sorafenib in Advanced Hepatocellular Carcinoma
2008 · 12.895 Zit.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · 11.410 Zit.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 · 10.610 Zit.
Management of Hepatocellular Carcinoma: An Update Δσ
2011 · 8.112 Zit.
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 · 7.097 Zit.